Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Stock Scan Q4 2017 – Q3 Reporting Chops $70bn From Pharma

Executive Summary

Big pharma stocks lost value overall in the fourth quarter of 2017 despite good performances from Asian companies and Kåre Schultz taking over at Teva.

Advertisement

Related Content

In Dry Eye, A Variety Of Mechanisms Pursue Established Therapies
Roche's Tecentriq-Avastin Combo Improves PFS In Kidney Cancer Too
Non-Inhibitor Data Secure Roche's Competitive Position In Hemophilia A
Stock Scan October: Generics Pull Pharma Down

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC100239

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel